ASCIA e-training courses are moving to new websites on Friday 17 January 2025, which will improve access to ASCIA training:

• ASCIA anaphylaxis e-training courses for schools, children’s education/care and community are moving to https://training.ascia.org.au/ 
• ASCIA e-training courses for health professionals are moving to https://traininghp.ascia.org.au/

Therefore we recommend that you complete any ASCIA courses you have started by Thursday 16 January 2025 as the current websites will be closed on Friday 17 January 2025. No accounts will be carried over to the new sites, so registration is required on the new sites.

This information has been added to current ASCIA e-training course websites.

ASCIA Course Updates 2025

The updated 2025 version of ASCIA anaphylaxis e-training for health professionals has been approved as a CPD activity by the Royal Australian College of General Practitioners (RACGP) and accredited by the Pharmaceutical Society of Australia (PSA) under the authority of the Australian Pharmacy Council (APC). 

It is important that ASCIA e-training courses are regularly reviewed and updated, as the usage continues to increase since they were first introduced in 2010. 

ASCIA e-training courses were completed by a total of 124,227 course participants in 2024, a 32% increase compared with 94,193 in 2023, including:

• 87,580 school course completions - an increase of 19% compared to 2023*
• 14,318 children's education/care course completions - an increase of 57% compared to 2023
• 14,011 health professional course completions - an increase of 150% compared to 2023

*Course completions in 2024 are in addition to completions of ASCIA anaphylaxis e-training courses licenced to be on NSW, QLD and WA Education Departments for use on their LMS platforms. 

This news item was issued on 10 January 2025 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.